Part, Chapter, Paragraph
1 II, 5. 11.Acr| Dermato-Epidemiological Network from psoriasis or psoriatic arthritis~NMSC~
2 II, 5. 11. 2| patients suffering from psoriasis or psoriatic arthritis~ ~
3 II, 5. 11. 3| suffering and incapacitation: psoriasis, atopic dermatitis, recalcitrant
4 II, 5. 11. 3| prevalence=9%~Mortz C, et al~Psoriasis~Summary of 18 population-based
5 II, 5. 11. 3| Coevorden et al, 2004).~ ~Psoriasis~Psoriasis is a common, chronic,
6 II, 5. 11. 3| et al, 2004).~ ~Psoriasis~Psoriasis is a common, chronic, relapsing,
7 II, 5. 11. 3| distinctive clinical variants of psoriasis are recognized. Plaque psoriasis
8 II, 5. 11. 3| psoriasis are recognized. Plaque psoriasis is most typically characterized
9 II, 5. 11. 3| of patients with plaque psoriasis also experience psoriatic
10 II, 5. 11. 3| flares or relapses of plaque psoriasis may also evolve into more
11 II, 5. 11. 3| pustular or erythrodermic psoriasis.~Psoriasis affects 1–5%
12 II, 5. 11. 3| erythrodermic psoriasis.~Psoriasis affects 1–5% of Europeans
13 II, 5. 11. 4| hand dermatitis or hand psoriasis confer a direct disability
14 II, 5. 11. 7| How patients experience psoriasis: results from a European
15 II, 5. 11. 7| Gudjonsson JE, Elder JT (2007): Psoriasis: epidemiology. Clin Dermatol
16 Key, Ap5. 0. 0| pseudomonas~psittacosis~psoriasis~psychiatric~psychiatrists~
